Sionna Therapeutics (SION) Capital Expenditures (2024 - 2025)
Sionna Therapeutics (SION) posted Capital Expenditures of $204000.0 for Q4 2025, up 134.48% sequentially from $87000.0 in Q3 2025, and up 655.56% YoY from $27000.0 in Q4 2024.
Sionna Therapeutics (SION) Capital Expenditures (2024 - 2025) Analysis & Trends
Sionna Therapeutics has reported Capital Expenditures for 2 years, with the latest figure at $204000.0 in Q4 2025.
- Quarterly Capital Expenditures rose 655.56% year-over-year to $204000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $291000.0 (up 157.52% YoY) and the FY2025 annual result came in at $377000.0, up 1296.3% from the prior year.
- Capital Expenditures advanced to $204000.0 in Q4 2025 per SION's latest filing, from $87000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $204000.0 in Q4 2025 and troughed at $27000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 204,000.00 |
| Dec 31, 2025 | 204,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |